Collaborations Pharmaceuticals, Inc., are pleased to announce their invitation from Reckitt to participate in The Science Inside Symposium 2024

Collaborations Pharmaceuticals, Inc., announce the opening of a new office in Raleigh, NC, to house their software development, business and operations teams.

Collaborations Pharmaceuticals, Inc. has developed a registry for Batten Disease CLN1 In order to find patients with this rare disease and gather information.

Collaborations Pharmaceuticals and Battelle published a new paper which demonstrated that an FDA approved drug may help in VX poisoning.

The National Institute of Neurological Disorders and Stroke has awarded a $3,953,139 SBIR grant to Collaborations Pharmaceuticals, Inc. for a Rare Disease